FDA data Registry peer set 1 peer FDA shortage listed

Alternatives to tamsulosin

FDA shortage status is active for tamsulosin; 1 same-class SPL records are listed below for registry comparison only.

Brand: Flomax

Alpha-1 Adrenergic Blocker Prescription 1 alternative found

tamsulosin class peers while FDA lists an active shortage

tamsulosin (Flomax) is on an FDA shortage listing while 1 other Alpha-1 Adrenergic Blocker SPL records remain in this registry peer set (class inventory 2). Labeled indication field for tamsulosin: This medicine treats the symptoms of an enlarged prostate, also known as benign prostatic hyperplasia (BPH).

Top FAERS reaction fields for tamsulosin total 9,736 reports across 10 reactions, set beside doxazosin. Counts are exposure-weighted submissions, not per-patient risk.

About tamsulosin

Tamsulosin (Flomax) helps to improve urination in men with enlarged prostate glands. It relaxes the muscles in the prostate and bladder, making it easier to urinate.

Used for: This medicine treats the symptoms of an enlarged prostate, also known as benign prostatic hyperplasia (BPH). BPH can cause problems with urination, like difficulty starting or stopping the flow of urine. Tamsulosin helps to relieve these symptoms.

1 Alpha-1 Adrenergic Blocker peers (wide set)

Compare tamsulosin vs doxazosin side-by-side →

tamsulosin vs doxazosin · FAERS reaction fields

FAERS top-reaction field "Dizziness" shows the widest count spread between tamsulosin and doxazosin in this extract (164-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.

Side Effect tamsulosin doxazosin
Fatigue 1,417 1,276
Dyspnoea 1,332 1,479
Dizziness 1,131 1,295
Diarrhoea 1,121 1,237
Headache 883 941
Asthenia 842 950
Fall 839 742
Nausea 808 1,131

"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.

tamsulosin shortage vs Alpha-1 Adrenergic Blocker peer index

Shortage status

FDA shortage listing is active for tamsulosin (status: To Be Discontinued). Peer rows remain a registry index, not a switch guide.

Frequently Asked Questions

Does FDA list a shortage for tamsulosin while peers remain indexed?
Yes - tamsulosin matched an active FDA shortage listing (To Be Discontinued) while 1 other Alpha-1 Adrenergic Blocker SPL records remain in this peer index for field comparison only.

Registry note: Shortage listings and peer indexes are for registry orientation only. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.

Full tamsulosin profile →

Field note for tamsulosin: see also the generic vs brand label guide when reading Flomax SPL strings.